Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001415889-24-017152

Options or other derivatives

  • Director acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NABEL ELIZABETH G · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-14 Grant or award : show line 1 in the form Option (right to buy) +130,000 130,000 D
Loading xslF345X05/form4-06172024_080605.xml…